Tag Archives: Gilead Sciences

Gilead Sciences (NASDAQ:GILD) Seeks Strenght in Blood Cancer Drugs; Spend $1.2 Billion in Previous Two Year

Gilead Sciences, Inc (NASDAQ:GILD) has invested $1.2 billion in 2 years to acquire blood cancer medicines. The Foster City, California based Gilead Sciences is the world’s biggest producer of HIV drugs.

Leukemia treatment and other blood cancers is one of …

Posted in Healthcare, Main Post | Tagged , , , , , , , , , , , | Comments Off

Merck (NYSE:MRK) Shatters Profit Guidance for Fiscal Year 2013; Fiscal Q4 Net Income Tumbles – MRK, GSK, NVS, BMY, GILD, JNJ, HLF, TEVA, CLSN

The Whitehouse Station, New Jersey-based Merck & Co, Inc’s (NYSE:MRK) current year profit forecasts tumbles as generic rivalry to its best selling medicine Singular will damage results.

The drug giant announced that earnings will be in the range of $3.60 …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Biogen Idec (NASDAQ:BIIB) Post 2.7% Drop in Fiscal Q4 on Higher Outlays – BIIB, CELG, GILD, CLSN, KERX, PFE, BSX, BMY, HLF

Biogen Idec Inc (NASDAQ:BIIB) reported fiscal Q4 earnings moved down 2.7% as the company’s attempts to increase its output pipeline masked its revenue expansion.

The biotechnology company also estimates fiscal year 2013 adjusted earnings in the range of $7.15 to …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) Updates Claim of a Healthy Pipeline

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) lately gave an update on its pipeline. Isis Pharmaclaims of a healthy pipeline. The firm thinks 5 of its pipeline candidates can get acceptance within the coming five years. Isis Pharmaanticipates data (phase II or phase …

Posted in Latest Headlines, Services | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Healthcare Stocks In focus; Gilead (GILD) Board Approve 2-for-1 Stock Split while Peregrine Pharmaceuticals (PPHM) Posts Narrower Loss inQ2 – GILD, PPHM, PFE, INFI, OREX, JNJ

Investors reacted positively to the healthcare stocks on Monday. Key movement were seen in Infinity Pharmaceuticals Inc (NASDAQ:INFI) and Orexigen Therapeutics, Inc (NASDAQ:OREX) on percentage gainers side while Johnson & Johnson (NYSE:JNJ) was prominent stock on most active side.

Gilead …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , | Comments Off

GlaxoSmithKline (NYSE:GSK) Plans to Buy Additional Stock in Indian Unit – GSK, MRK, NVS, SRPT, CTIC, SQNM, ESRX, STJ, GILD

GlaxoSmithKline PLC (NYSE:GSK)has shown interest in purchasing a further stake of almost 31.8% in its Indian division, GlaxoSmithKline Consumer Healthcare Ltd. , at 3,900 rupees ($70.3) a share, the UK-located firm stated in a report on Monday.

The proposal is …

Posted in Healthcare, Latest Headlines | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off